FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034248303> ?p ?o ?g. }

• W2034248303 endingPage "2655" @default.
• W2034248303 startingPage "2646" @default.
• W2034248303 abstract "To compare the efficacy and tolerability of losartan, an antagonist of angiotensin II receptor type 1, with nifedipine for the treatment of primary and secondary Raynaud's phenomenon (RP) in a pilot study.In a randomized, parallel-group, controlled trial, patients with primary RP (n = 25) or RP secondary to systemic sclerosis (SSc [scleroderma]; n = 27) were allocated to receive 12 weeks' treatment with either losartan (50 mg/day) or nifedipine (40 mg/day). Primary outcome variables were the severity and frequency of RP episodes and findings on vascular measurements, including thermography and laser Doppler flowmetry. Serum levels of soluble adhesion molecules, endothelin 1, fibrinogen, von Willebrand factor, and procollagen type I N-terminal propeptide (PINP) were also measured.There was a reduction in the severity of RP episodes following treatment with losartan and with nifedipine, but this effect was greater in the losartan arm of the study (P<0.05): episode frequency was reduced only in the losartan group (P<0.01 versus baseline). Symptomatic improvement was associated with a significant reduction in soluble vascular cell adhesion molecule 1 and PINP (P<0.01). Subgroup analysis suggested that although these biochemical changes occurred mainly in SSc patients, the clinical benefit was greater in the primary RP group.This study confirms the tolerability of short-term treatment of RP with losartan, and our data suggest its clinical benefit. Further evaluation of this drug as a long-term treatment for SSc-associated RP should be considered, since it may have additional disease-modifying potential." @default.
• W2034248303 created "2016-06-24" @default.
• W2034248303 creator A5003204625 @default.
• W2034248303 creator A5008098676 @default.
• W2034248303 creator A5020043757 @default.
• W2034248303 creator A5028206850 @default.
• W2034248303 creator A5029200804 @default.
• W2034248303 creator A5076002640 @default.
• W2034248303 creator A5084901606 @default.
• W2034248303 date "1999-12-01" @default.
• W2034248303 modified "2023-10-14" @default.
• W2034248303 title "Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial" @default.
• W2034248303 cites W1520455694 @default.
• W2034248303 cites W1674647355 @default.
• W2034248303 cites W1964958603 @default.
• W2034248303 cites W1981403699 @default.
• W2034248303 cites W1993324126 @default.
• W2034248303 cites W1999701858 @default.
• W2034248303 cites W2005142587 @default.
• W2034248303 cites W2010276857 @default.
• W2034248303 cites W2014616104 @default.
• W2034248303 cites W2022103556 @default.
• W2034248303 cites W2028921539 @default.
• W2034248303 cites W2037609753 @default.
• W2034248303 cites W2041689662 @default.
• W2034248303 cites W2058661403 @default.
• W2034248303 cites W2062915042 @default.
• W2034248303 cites W2063670795 @default.
• W2034248303 cites W2066856537 @default.
• W2034248303 cites W2070986045 @default.
• W2034248303 cites W2072628367 @default.
• W2034248303 cites W2084031809 @default.
• W2034248303 cites W2091944102 @default.
• W2034248303 cites W2093840077 @default.
• W2034248303 cites W2106761396 @default.
• W2034248303 cites W2120466648 @default.
• W2034248303 cites W2122783145 @default.
• W2034248303 cites W2125255718 @default.
• W2034248303 cites W2134960542 @default.
• W2034248303 cites W2135575492 @default.
• W2034248303 cites W2143266804 @default.
• W2034248303 cites W2147834144 @default.
• W2034248303 cites W2149568156 @default.
• W2034248303 cites W2166493507 @default.
• W2034248303 cites W2172116313 @default.
• W2034248303 cites W2505400567 @default.
• W2034248303 cites W4238589791 @default.
• W2034248303 cites W2045860861 @default.
• W2034248303 doi "https://doi.org/10.1002/1529-0131(199912)42:12<2646::aid-anr21>3.0.co;2-t" @default.
• W2034248303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10616013" @default.
• W2034248303 hasPublicationYear "1999" @default.
• W2034248303 type Work @default.
• W2034248303 sameAs 2034248303 @default.
• W2034248303 citedByCount "275" @default.
• W2034248303 countsByYear W20342483032012 @default.
• W2034248303 countsByYear W20342483032013 @default.
• W2034248303 countsByYear W20342483032014 @default.
• W2034248303 countsByYear W20342483032015 @default.
• W2034248303 countsByYear W20342483032016 @default.
• W2034248303 countsByYear W20342483032017 @default.
• W2034248303 countsByYear W20342483032018 @default.
• W2034248303 countsByYear W20342483032019 @default.
• W2034248303 countsByYear W20342483032020 @default.
• W2034248303 countsByYear W20342483032021 @default.
• W2034248303 countsByYear W20342483032022 @default.
• W2034248303 countsByYear W20342483032023 @default.
• W2034248303 crossrefType "journal-article" @default.
• W2034248303 hasAuthorship W2034248303A5003204625 @default.
• W2034248303 hasAuthorship W2034248303A5008098676 @default.
• W2034248303 hasAuthorship W2034248303A5020043757 @default.
• W2034248303 hasAuthorship W2034248303A5028206850 @default.
• W2034248303 hasAuthorship W2034248303A5029200804 @default.
• W2034248303 hasAuthorship W2034248303A5076002640 @default.
• W2034248303 hasAuthorship W2034248303A5084901606 @default.
• W2034248303 hasConcept C126322002 @default.
• W2034248303 hasConcept C126894567 @default.
• W2034248303 hasConcept C134018914 @default.
• W2034248303 hasConcept C197934379 @default.
• W2034248303 hasConcept C2778375690 @default.
• W2034248303 hasConcept C2779066535 @default.
• W2034248303 hasConcept C2780288358 @default.
• W2034248303 hasConcept C2908929049 @default.
• W2034248303 hasConcept C519063684 @default.
• W2034248303 hasConcept C71924100 @default.
• W2034248303 hasConcept C84393581 @default.
• W2034248303 hasConcept C90924648 @default.
• W2034248303 hasConceptScore W2034248303C126322002 @default.
• W2034248303 hasConceptScore W2034248303C126894567 @default.
• W2034248303 hasConceptScore W2034248303C134018914 @default.
• W2034248303 hasConceptScore W2034248303C197934379 @default.
• W2034248303 hasConceptScore W2034248303C2778375690 @default.
• W2034248303 hasConceptScore W2034248303C2779066535 @default.
• W2034248303 hasConceptScore W2034248303C2780288358 @default.
• W2034248303 hasConceptScore W2034248303C2908929049 @default.
• W2034248303 hasConceptScore W2034248303C519063684 @default.
• W2034248303 hasConceptScore W2034248303C71924100 @default.
• W2034248303 hasConceptScore W2034248303C84393581 @default.
• W2034248303 hasConceptScore W2034248303C90924648 @default.

• next